Sven Kronenberg

647 total citations
23 papers, 426 citations indexed

About

Sven Kronenberg is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Sven Kronenberg has authored 23 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 9 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Molecular Biology. Recurrent topics in Sven Kronenberg's work include Biosimilars and Bioanalytical Methods (11 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and CAR-T cell therapy research (5 papers). Sven Kronenberg is often cited by papers focused on Biosimilars and Bioanalytical Methods (11 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and CAR-T cell therapy research (5 papers). Sven Kronenberg collaborates with scholars based in Switzerland, Germany and United States. Sven Kronenberg's co-authors include Annika Herrmann, Björn Jacobsen, Michael B. Otteneder, Andreas Baumann, Gustavo D. Aguirre, Maria Cristina De Vera Mudry, Lolke de Haan, Charlotte Esser, Jacques Gaudreault and Christophe Schmitt and has published in prestigious journals such as Nucleic Acids Research, PLANT PHYSIOLOGY and Cancer Research.

In The Last Decade

Sven Kronenberg

22 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sven Kronenberg Switzerland 12 162 139 116 60 43 23 426
Meric Ovacik United States 8 208 1.3× 81 0.6× 165 1.4× 77 1.3× 15 0.3× 17 407
Shuji Matsuoka Japan 12 199 1.2× 254 1.8× 81 0.7× 74 1.2× 8 0.2× 21 585
Karunakaran Coral India 17 192 1.2× 42 0.3× 69 0.6× 64 1.1× 17 0.4× 28 504
Marleen Kawahara United States 8 141 0.9× 216 1.6× 33 0.3× 70 1.2× 60 1.4× 8 473
I. Jaffe United States 11 147 0.9× 71 0.5× 46 0.4× 32 0.5× 28 0.7× 19 475
Danielle Roman Switzerland 11 101 0.6× 48 0.3× 22 0.2× 49 0.8× 60 1.4× 27 358
John A. Wijsman Canada 13 160 1.0× 108 0.8× 32 0.3× 128 2.1× 28 0.7× 19 524
Yasushi Ohmachi Japan 14 164 1.0× 75 0.5× 110 0.9× 53 0.9× 6 0.1× 35 527
Castle Funatake United States 11 95 0.6× 525 3.8× 18 0.2× 113 1.9× 12 0.3× 13 689
Mariarosa Perotti Italy 8 268 1.7× 66 0.5× 63 0.5× 47 0.8× 6 0.1× 16 495

Countries citing papers authored by Sven Kronenberg

Since Specialization
Citations

This map shows the geographic impact of Sven Kronenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven Kronenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven Kronenberg more than expected).

Fields of papers citing papers by Sven Kronenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sven Kronenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven Kronenberg. The network helps show where Sven Kronenberg may publish in the future.

Co-authorship network of co-authors of Sven Kronenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Sven Kronenberg. A scholar is included among the top collaborators of Sven Kronenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sven Kronenberg. Sven Kronenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lechmann, Martin, Katharine Bray‐French, Anneliese Schneider, et al.. (2025). Comparable immunogenicity of new modality biotherapeutics delivered subcutaneously or intravenously in non-human primates. Journal of Immunotoxicology. 22(1). 2537408–2537408.
2.
Grimaldi, Christine, Andrea Kießling, Benno Rattel, et al.. (2022). Current nonclinical approaches for immune assessments of immuno-oncology biotherapeutics. Drug Discovery Today. 28(2). 103440–103440. 3 indexed citations
3.
Ackley, David H., Todd Bourcier, Andrew L. Goodwin, et al.. (2022). FDA and industry collaboration: Identifying opportunities to further reduce reliance on nonhuman primates for nonclinical safety evaluations. Regulatory Toxicology and Pharmacology. 138. 105327–105327. 22 indexed citations
4.
Hey, Adam, Andreas Baumann, Sven Kronenberg, et al.. (2021). Nonclinical Development of Biologics: Integrating Safety, Pharmacokinetics, and Pharmacodynamics to Create Smarter and More Flexible Nonclinical Safety Programs Optimizing Animal Use. International Journal of Toxicology. 40(3). 270–284. 2 indexed citations
5.
Baumann, Andreas, Sven Kronenberg, Adam Hey, et al.. (2021). Challenges of non-clinical safety testing for biologics: A Report of the 9th BioSafe European Annual General Membership Meeting. mAbs. 13(1). 1938796–1938796. 6 indexed citations
6.
7.
MacLachlan, Timothy K., Sven Kronenberg, Nikki B. Marshall, et al.. (2020). Industry experiences with immune-mediated findings in biotherapeutic nonclinical toxicology studies. Regulatory Toxicology and Pharmacology. 119. 104825–104825. 2 indexed citations
8.
Ulrich, Peter, Andreas Baumann, Adam Hey, et al.. (2018). Biotherapeutics in non-clinical development: Strengthening the interface between safety, pharmacokinetics-pharmacodynamics and manufacturing. Regulatory Toxicology and Pharmacology. 94. 91–100. 6 indexed citations
9.
Moisan, Annie, Francesca Michielin, Wolfgang Jacob, et al.. (2018). Mechanistic Investigations of Diarrhea Toxicity Induced by Anti-HER2/3 Combination Therapy. Molecular Cancer Therapeutics. 17(7). 1464–1474. 18 indexed citations
10.
Kronenberg, Sven, Christine M. Schubert, Christian Freichel, et al.. (2017). Comparative assessment of immune complex-mediated hypersensitivity reactions with biotherapeutics in the non-human primate: Critical parameters, safety and lessons for future studies. Regulatory Toxicology and Pharmacology. 88. 125–137. 17 indexed citations
11.
Jacobsen, Björn, et al.. (2017). Distribution of FcRn Across Species and Tissues. Journal of Histochemistry & Cytochemistry. 65(6). 321–333. 124 indexed citations
12.
Baumann, Andreas, Sven Kronenberg, Lolke de Haan, et al.. (2016). Non-clinical Safety Evaluation of Biotherapeutics – Challenges, Opportunities and new Insights. Regulatory Toxicology and Pharmacology. 80. S1–S14. 15 indexed citations
13.
Brennan, Frank R., Andreas Baumann, Lolke de Haan, et al.. (2015). Nonclinical safety testing of biopharmaceuticals – Addressing current challenges of these novel and emerging therapies. Regulatory Toxicology and Pharmacology. 73(1). 265–275. 13 indexed citations
14.
Baumann, Andreas, Kelly M. Flagella, Roy Forster, et al.. (2014). New challenges and opportunities in nonclinical safety testing of biologics. Regulatory Toxicology and Pharmacology. 69(2). 226–233. 19 indexed citations
15.
Kling, Dorothée, Sven Kronenberg, Dietrich Tuerck, et al.. (2013). Pharmacological control of platelet-leukocyte interactions by the human anti-P-selectin antibody inclacumab – preclinical and clinical studies. Thrombosis Research. 131(5). 401–410. 41 indexed citations
16.
Kronenberg, Sven, Andreas Baumann, Lolke de Haan, et al.. (2013). Current challenges and opportunities in nonclinical safety testing of biologics. Drug Discovery Today. 18(23-24). 1138–1143. 18 indexed citations
17.
Richter-Hintz, Dagmar, Sven Kronenberg, Ellen Fritsche, et al.. (2003). Allelic Variants of Drug Metabolizing Enzymes as Risk Factors in Psoriasis. Journal of Investigative Dermatology. 120(5). 765–770. 32 indexed citations
18.
Böttcher, Bettina, Sven Kronenberg, & Jörg H. Kleinschmidt. (2002). Electron Cryo-microscopy and Image Reconstruction of Adeno-Associated Virus Type 2 empty Capsids. Microscopy and Microanalysis. 8(S02). 212–213. 3 indexed citations
19.
Kronenberg, Sven. (2000). An aryl hydrocarbon receptor conformation acts as the functional core of nuclear dioxin signaling. Nucleic Acids Research. 28(12). 2286–2291. 35 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Meric Ovacik Breakdown of academic impact, for papers by Shuji Matsuoka Breakdown of academic impact, for papers by Karunakaran Coral Breakdown of academic impact, for papers by Marleen Kawahara Breakdown of academic impact, for papers by I. Jaffe Breakdown of academic impact, for papers by Danielle Roman Breakdown of academic impact, for papers by John A. Wijsman Breakdown of academic impact, for papers by Yasushi Ohmachi Breakdown of academic impact, for papers by Castle Funatake Breakdown of academic impact, for papers by Mariarosa Perotti
Rankless by CCL
2026